Serum YKL-40 Level Is Associated with the Chemotherapy Response and Prognosis of Patients with Small Cell Lung Cancer

Open Access

Peer-reviewed

Research Article

Chun-Hua Xu,

Affiliations First Department of Respiratory Medicine and Nanjing Chest Hospital, Nanjing, Jiangsu, China, Clinical Center of Nanjing Respiratory Diseases, Nanjing, Jiangsu, China
⨯
Li -Ke Yu ,

* E-mail: yulike_doctor@163.com

Affiliations First Department of Respiratory Medicine and Nanjing Chest Hospital, Nanjing, Jiangsu, China, Clinical Center of Nanjing Respiratory Diseases, Nanjing, Jiangsu, China
⨯
Ke-Ke Hao

Affiliations First Department of Respiratory Medicine and Nanjing Chest Hospital, Nanjing, Jiangsu, China, Clinical Center of Nanjing Respiratory Diseases, Nanjing, Jiangsu, China
⨯

Reader Comments (0)

Small cell lung cancer
Is the Subject Area "Small cell lung cancer" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Gastric cancer
Is the Subject Area "Gastric cancer" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.